OKEP 02 Dec 16

Is this your test? Login to manage it. If not, you can develop an exam just like it.

This is a non-interactive preview of the quiz content.

1.
Full Name:
2.
Territory:
3.
Email Id:
4.
Levetiracetam belongs to:
5.
Levetiracetam was approved by the CDRI in the year _____ as an adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy?
6.
Three major molecular targets inlcudes ?
7.
Total Levetiracetam Market for August 2016 and growth is (INR Crs)?
8.
Which of the following class of drug of Levetiracetam growing at most among the following?
9.
Total Market (MAT OCT 2016) of LEVERA from Intas is valued of ____ and growing at the rate of ___ (INR Crs)?
10.
Levetiracetam treatment should be initiated _______ dose range for Partial Onset Seizures in patient with Ages 4 To <16 Years?
11.
Levetiracetam has ability to hyperpolarize membrane potential via
12.
The dosing of Levetiracetam varies according to indication. A patient suffering the chronic kidney disease (CKD) with GFR < 30mL/min/1.73 m 2 and suffering with seizures at the age 68 been prescribed for levetiracetam tablet; What will be the dose of drug?